New Agents for the Treatment of Acute Lymphoblastic Leukemia /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2011.
|
| Edición: | 1st ed. 2011. |
| Materias: |
Tabla de Contenidos:
- The need for new agents
- Identifying pre-clinical agents
- Pre-clinical evaluation
- Design of early phase trials
- Strategies for trial design and analyses
- Overview on Molecular and Animal models of ALL
- Apoptosis, BCL2
- Targeting Stem Cells
- Nucleoside Analogues
- Flt3 Inhibitors
- Tyrosine Kinase Inhibitors
- Monoclonal Antibodies
- Proteasome inhibitors
- Targeting epigenetic pathways in ALL.- Incorporating new therapies in frontline protocols.-.